Anchor Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $720K | Buy |
1,617
+2
| +0.1% | +$890 | 0.06% | 219 |
|
|
2025
Q1 | $783K | Buy |
1,615
+209
| +15% | +$101K | 0.07% | 206 |
|
|
2024
Q4 | $566K | Sell |
1,406
-177
| -11% | -$71.3K | 0.05% | 236 |
|
|
2024
Q3 | $736K | Buy |
1,583
+1,474
| +1,352% | +$686K | 0.07% | 219 |
|
|
2024
Q2 | $51.1K | Sell |
109
-2,032
| -95% | -$952K | 0.01% | 514 |
|
|
2024
Q1 | $895K | Buy |
2,141
+168
| +9% | +$70.2K | 0.09% | 190 |
|
|
2023
Q4 | $803K | Buy |
1,973
+297
| +18% | +$121K | 0.09% | 188 |
|
|
2023
Q3 | $583K | Buy |
1,676
+378
| +29% | +$131K | 0.08% | 213 |
|
|
2023
Q2 | $457K | Buy |
1,298
+633
| +95% | +$223K | 0.06% | 240 |
|
|
2023
Q1 | $210K | Buy |
665
+41
| +7% | +$12.9K | 0.03% | 337 |
|
|
2022
Q4 | $180K | Buy |
624
+614
| +6,140% | +$177K | 0.03% | 351 |
|
|
2022
Q3 | $2.9K | Hold |
10
| – | – | ﹤0.01% | 863 |
|
|
2022
Q2 | $2.82K | Hold |
10
| – | – | ﹤0.01% | 867 |
|
|
2022
Q1 | $2.61K | Hold |
10
| – | – | ﹤0.01% | 894 |
|
|
2021
Q4 | $2.2K | Hold |
10
| – | – | ﹤0.01% | 930 |
|
|
2021
Q3 | $1.81K | Hold |
10
| – | – | ﹤0.01% | 864 |
|
|
2021
Q2 | $2.02K | Sell |
10
-675
| -99% | -$136K | ﹤0.01% | 879 |
|
|
2021
Q1 | $147K | Buy |
685
+525
| +328% | +$113K | 0.02% | 384 |
|
|
2020
Q4 | $37.8K | Buy |
160
+115
| +256% | +$27.2K | 0.01% | 511 |
|
|
2020
Q3 | $12.2K | Buy |
45
+35
| +350% | +$9.52K | ﹤0.01% | 626 |
|
|
2020
Q2 | $2.9K | Buy |
+10
| New | +$2.9K | ﹤0.01% | 754 |
|